Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma

NCT00002909 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Cancer Institute (NCI)